List of bibliographic references
Number of relevant bibliographic references: 10.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Genotype |
| 3 | Gastroenterology |
| 3 | Viral hepatitis C |
| 2 | Adolescent |
| 2 | Adult |
| 2 | Aged |
| 2 | Antiviral |
| 2 | Female |
| 2 | Humans |
| 2 | Insulin resistance |
| 2 | Interferon-alpha (therapeutic use) |
| 2 | Male |
| 2 | Medicine |
| 2 | Middle Aged |
| 2 | Polyethylene Glycols (therapeutic use) |
| 2 | Recombinant Proteins (therapeutic use) |
| 2 | Typing |
| 2 | Young Adult |
| 1 | Administration, Oral |
| 1 | Alanine transaminase |
| 1 | Albinterferon alfa-2b |
| 1 | Antineoplastic agent |
| 1 | Antiretroviral agent |
| 1 | Antiviral Agents (administration & dosage) |
| 1 | Antiviral Agents (therapeutic use) |
| 1 | Antiviral therapy |
| 1 | Baseline |
| 1 | Body mass index |
| 1 | Brosis |
| 1 | Caucasian |
| 1 | Causal relationship |
| 1 | Centile |
| 1 | Cholesterol levels |
| 1 | Chronic hepatitis |
| 1 | Clearance |
| 1 | Cohort |
| 1 | Continuous variables |
| 1 | Data acquisition |
| 1 | Data analysis |
| 1 | Diabetes |
| 1 | Diabetes mellitus |
| 1 | Dose-Response Relationship, Drug |
| 1 | Drug Administration Schedule |
| 1 | Drug Therapy, Combination |
| 1 | Fasting |
| 1 | Follow-Up Studies |
| 1 | Glucose |
| 1 | Hepacivirus (genetics) |
| 1 | Hepatic |
| 1 | Hepatic steatosis |
| 1 | Hepatitis |
| 1 | Hepatitis B Surface Antigens (blood) |
| 1 | Hepatitis B Surface Antigens (drug effects) |
| 1 | Hepatitis B, Chronic (blood) |
| 1 | Hepatitis B, Chronic (diagnosis) |
| 1 | Hepatitis B, Chronic (drug therapy) |
| 1 | Hepatitis B, Chronic (mortality) |
| 1 | Hepatitis C, Chronic (drug therapy) |
| 1 | Hepatitis C, Chronic (virology) |
| 1 | Hepatocellular |
| 1 | Hepatocellular carcinoma |
| 1 | Hepatol |
| 1 | Hepatology |
| 1 | Homeostasis |
| 1 | Human |
| 1 | Human genome sciences |
| 1 | Immunomodulator |
| 1 | Injections, Subcutaneous |
| 1 | Insulin |
| 1 | Insulin sensitivity |
| 1 | Interferon |
| 1 | Interferon-alpha (administration & dosage) |
| 1 | Internationality |
| 1 | Kaplan-Meier Estimate |
| 1 | Lamivudine |
| 1 | Lipid |
| 1 | Liver histology |
| 1 | Manuscript revision |
| 1 | Markov Chains |
| 1 | Median |
| 1 | Mellitus |
| 1 | Metavir |
| 1 | Metavir activity |
| 1 | Metavir stage |
| 1 | Models, Theoretical |
| 1 | Multivariable |
| 1 | Novartis |
| 1 | Peginterferon alfa-2a |
| 1 | Polyethylene Glycols (administration & dosage) |
| 1 | Prognosis |
| 1 | Recombinant Proteins (administration & dosage) |
| 1 | Research grants |
| 1 | Research institute |
| 1 | Retrospective Studies |
| 1 | Ribavirin (administration & dosage) |
| 1 | Ribavirin (therapeutic use) |
| 1 | Risk Assessment |
| 1 | Roche |
| 1 | Severity of Illness Index |
| 1 | Steatosis |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Robert Flisiak"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Robert Flisiak" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Robert Flisiak
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
